Which Strategies Are Most Likely to Defeat Coronavirus?
A recent review study suggests that the development of certain antivirals and gene therapy are likely to progress quickest in the fight against dangerous coronviruses such as SARS-CoV-2
gene therapy
Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors
AAV analysis allows researchers to determine titer, full:empty capsid ratio, and aggregation in single 30-minute run
New Blood Donor Center Opens to Support Boston-Area Research into COVID-19 Therapies, Vaccines, and Diagnostics
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection
Lonza Launches New TheraPEAK™ SfAAV™ Medium to Boost and Optimize the Production of AAV in Sf9 Insect Cells
TheraPEAK™ SfAAV™ Medium is specifically designed to support the development of safe, scalable, life-saving gene therapies
BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations
BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research
Gene Therapy Generates New Neurons to Treat Huntington's Disease
Researchers have developed a novel gene therapy to regenerate functional new neurons in mouse models of Huntington's disease
CRISPR-Edited Immune Cells Can Survive and Thrive after Infusion into Cancer Patients
New data on first-in-US trial sheds new light on success of gene editing and cell function
6 Patients with Rare Blood Disease Doing Well after Gene Therapy Clinical Trial
Treatment uses person's own stem cells instead of donor cells
Horizon Discovery to Provide Access to Novel Base Editing Technology
Next-generation gene editing system has applications in development of cell and gene therapies
Researchers Create Functional Mini-Liver by 3D Bioprinting
Technique developed at Human Genome and Stem Cell Research Center, funded by FAPESP and hosted by the University of São Paulo, produced hepatic tissue in the laboratory in only 90 days and could become an alternative to organ transplantation in future